Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

A case of suicide attempt with long-acting methylphenidate (Concerta).

Ozdemir E, Karaman MG, Yurteri N, Erdogan A.

Atten Defic Hyperact Disord. 2010 Nov;2(3):103-5. doi: 10.1007/s12402-010-0026-y. Epub 2010 May 25.

PMID:
21432595
2.

Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.

Scharman EJ, Erdman AR, Cobaugh DJ, Olson KR, Woolf AD, Caravati EM, Chyka PA, Booze LL, Manoguerra AS, Nelson LS, Christianson G, Troutman WG; American Association of Poison Control Centers.

Clin Toxicol (Phila). 2007 Oct-Nov;45(7):737-52.

PMID:
18058301
4.

[Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].

Shmueli D, Gross-Tsur V.

Harefuah. 2005 Aug;144(8):572-6, 597. Review. Hebrew.

PMID:
16146157
5.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
6.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
7.

Abuse and toxicity of methylphenidate.

Klein-Schwartz W.

Curr Opin Pediatr. 2002 Apr;14(2):219-23. Review.

PMID:
11981294
8.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
9.
11.
13.

[Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].

Oberpichler-Schwenk H.

Med Monatsschr Pharm. 2006 Nov;29(11):415-6. Review. German. No abstract available.

PMID:
17131689
14.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
15.

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential.

Connor DF, Steingard RJ.

CNS Drugs. 2004;18(14):1011-30. Review.

PMID:
15584770
17.

A Case Report of Reversible Takotsubo Cardiomyopathy after Amphetamine/Dextroamphetamine Ingestion in a 15-Year-Old Adolescent Girl.

Toce MS, Farias M, Bruccoleri R, Brown DW, Burns MM.

J Pediatr. 2017 Mar;182:385-388.e3. doi: 10.1016/j.jpeds.2016.11.038. Epub 2016 Dec 13. Review.

PMID:
27979580
18.

Caffeine and suicide: a systematic review.

Silva AC, de Oliveira Ribeiro NP, de Mello Schier AR, Pereira VM, Vilarim MM, Pessoa TM, Arias-CarriĆ³n O, Machado S, Nardi AE.

CNS Neurol Disord Drug Targets. 2014;13(6):937-44. Review.

PMID:
24923334

Supplemental Content

Support Center